ABSTRACT Eight male subjects were experimentally exposed to toluene, p-xylene, and a combination of toluene and p-xylene in order to study the influence of coexposure and exposure to different levels of each solvent on their uptake and elimination. The exposures were performed for four hours at exposure levels equivalent to or lower than the Swedish threshold limit value for toluene, 300 mg/m3 (3.2 mmollm3). During and after the exposure, solvent concentrations were measured in blood and in expired air. In addition, the pulmonary ventilation rate was measured during the exposure. Decreases in the blood/end exhaled air concentration ratio were found for both toluene and p-xylene when given in combination compared with separate exposure. The total solvent uptake relative to the exposure level was decreased after exposure to the higher solvent concentrations, and the apparent clearance was also decreased after exposure to the higher concentrations of solvent. Finally, the blood solvent concentrations were lower at the end of the exposure compared with the maximal concentration during each exposure condition. In the kinetics of toluene and p-xylene the total amount of toluene or p-xylene, or both, seems to be of major importance. possible to replicate in man or in rats exposed to low doses of m-xylene.9 With this information to hand there seemed to be a need to study the effects on the uptake and elimination of commonly used organic solvents by simultaneous exposure to more than one solvent at a total level of exposure not exceeding the threshold limit value. In the present investigation subjects were exposed to toluene and p-xylene, both of which frequently occur in the industrial environment either singly or in combination as, for example, while working with thinners used for paints or in the printing trade. Furthermore, some metabolic interaction or dose dependent kinetics, or both, would be expected, especially at higher doses, since the main metabolic pathway is the same for toluene and xylenenamely, microsomal hydroxylation by cytochrome P-450 and further oxidation through alcohol and aldehyde dehydrogenases to the corresponding acid."0-'3 This metabolic pathway, like all enzymatically mediated processes, is limited by capacity. The main purpose of the present investigation was to study how the uptake and elimination of toluene and p-xylene in man were influenced by coexposure and by exposure to different levels of each solvent. 111
Occupational exposure to organic solvents more commonly necessitates simultaneous exposure to several different solvents than to one only. Several observations indicate that the kinetics of the uptake and elimination of separate organic solvents may change when more than one solvent is present at the same time.
In the rat the in vivo metabolism of high doses of trichloroethylene,' n-hexane,2 benzene,34 styrene, 35 and methylene chloride6 is inhibited by coexposure to toluene. The metabolism of toluene in the rat is likewise inhibited by simultaneous exposure to trichloroethylene and benzene. '4 In man toluene and benzene do not influence the metabolism of each other during short term exposure using exposure levels at the Swedish threshold limit value. 4 Nevertheless, a decrease in the rate of metabolism of toluene and of m-xylene has been shown in man after ingesting ethanol.78 Phenobarbital treatment of rats before the administration of high doses of toluene or m-xylene enhances the rate of metabolism of the solvents,2 39 10 an effect that has not been 112 Subjects, material, and methods Eight healthy men (age 26-37, weight 59-74 kg, height 170-183 cm) with no. occupational exposure to organic solvents, were examined for four hours during and for two hours after exposure to toluene or p-xylene, or both, under different conditions. The levels of exposure were chosen such that the total amount of solvent in the high level toluene exposure, T(H), the high level p-xylene exposure, X(H), and the combined exposure, T(C) + X(C), was equivalent to the Swedish threshold limit value of toluene, expressed in mg/m3. The solvent concentrations in the inspired air during these exposures, together with those at the low level exposures to toluene, T(L), and to p-xylene, X(L), are shown in table 1. The experiments were carried out at intervals of two weeks and the subjects were exposed in pairs under standardised conditions in an exposure chamber (volume 12 m3, air change 10 times/h, inlet air flow 115 m3/h, outlet air flow 135 m3/h). Solvent vapour was generated by passing compressed air through solvent filled wash bottles at constant temperature (34 5°C ) and the desired concentrations were obtained by diluting with fresh air. The concentration of solvent in the exposure chamber was continuously monitored using a spectrophotometric method (Miran IA, infrared detector). In addition, intermittent monitoring was performed using gas chromatography (Antec 464 LP, flame ionisation detector, 5% Bentone + 5% SP 1000 on Supelcoport, temperature 100°C, nitrogen flow 25 ml/ min). The same gas chromatographic equipment was used to analyse samples of end exhaled (alveolar) air and expired air for calculating the uptake of the solvent.
During four periods of eight minutes equally distributed throughout the exposure, expired air was collected into bags made of polyester laminated aluminium foil for the determination of solvent concentration and pulmonary ventilation per unit time. The air volume was measured with a balanced spirometer and the amount of solvent taken up during each sampling period was calculated as the difference between the total amount of solvent in the inspired and expired air. The experimental error was estimated to be +3%. '4 The total uptake during the whole exposure period was calculated from the mean amounts taken up during each eight minute period. End exhaled air was sampled at the end of a normal exhalation and its solvent concentration was determined. To collect end exhaled air the subject was asked to take three normal breaths through a glass tube (volume 35 ml) and to close it tightly at both ends immediately after the third exhalation.
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093+-0(02 Control= fresh air *Sequence of the exposure conditions T(H), X(H), T(C) + X(C), and fresh air was based on a Latin square 4x 4 design whereas low level exposures T(L) and X(L) were carried out as a later series of exposures. tCorresponds to 300 mg/m3, the Swedish threshold limit value for toluene.
The total error when sampling during exposure was estimated to be ± 10% of the mean value for toluene and ± 13% for p-xylene. The corresponding values after the end of exposure were + 14% and ± 19% respectively.
The analysis of solvent concentrations in the blood was carried out using capillary samples from a finger. When the specimens were collected during the exposure the volunteers held out a hand through a closeable hole (diameter 9 cm) in the chamber wall. The blood (50-250 ,ul) was collected in gastight citrate treated head space bottles with Teflon lined membranes. A standardised volume of distilled water was added to haemolyse the blood.'5 Blood volumes were determined by weighing, and the samples were analysed using a gas chromatograph (Perkin Elmer F45, flame ionisation detector, 5% OV-17 on Chromosorb G, temperature 1 10°C, nitrogen flow 25 ml/min) and head space analysis after equilibration of the solvent at 37°C for at least 30 minutes. To calculate the blood solvent concentrations, individual blood/air partition coefficients for toluene and p-xylene were determined in venous blood collected immediately before the onset of each exposure. The determination of individual partition coefficients was made from a 100 ,ul blood volume and solvent concentrations determined in other volumes were standardised to this volume. The error was estimated to be + 10% for the determination of toluene in blood and + 12% for p-xylene, the lower limit of detection was estimated to be 0-2 ,umolI for both toluene and p-xylene. Student 
tt = duration of exposure, C;n = solvent concentration in inspired air, and Cex = solvent concentration in expired air.
macokinetic calculations were based on those of Rowland and Tozer. '6 Results
The mean relative uptake was 53% for toluene and 58% for p-xylene (table 2) , and no differences were seen between the four periods of sampling during the same exposure. No statistically significant differences were noted in the relative uptake of toluene during the three types of exposure to toluene, but a Table 3 gives the concentration ratios between the solvent concentration in the blood and that in the end exhaled air at the time of maximal blood solvent concentration (N). The concentration ratio calculated from exposure condition T(H) was higher than that from T(C), that from X(H) was higher than from X(C), and that from X(C) was lower than from X(L). No difference could be found from exposure Coexposure to toluene and p-xylene in man: uptake and elimination each solvent at high level. In vitro no change in the blood/air partition coefficient of toluene could be seen during coincubation with benzene. 4 No statistically significant differences were seen in the relative uptake (F) during coexposure when compared with the high level exposure to each solvent despite the difference noted in the blood/air concentration ratios. A decrease in F was seen for p-xylene, however, during coexposure when compared with the low level exposure. A similar trend was seen during the corresponding toluene exposures. The decrease in F is probably best explained by a corresponding decrease in the value of VA/VE in
conditions T(H) and T(L), T(C) and T(L), or X(H) and X(L)
The ratio (N-Neff)/N remained constant for the different toluene and p-xylene exposure conditions.
An influence on VA/VE may also explain the discrepancies between the experimental and estimated values of N, where, for the latter, values of VAlVE was considered to be constant (table 3) . Toluene and p-xylene at exposure levels below or equivalent to the Swedish threshold limit value are not reported to affect lung function at rest.23 Available data merely describe a dose dependent effect on the respiratory rate in mice with large doses of toluene and xylene24 2S and an acute narcotic effect in man due to high level exposure to organic solvents. 26 When calculating the apparent clearance, the total uptake of solvent was taken as the dose since small non-ionised lipophilic molecules have the ideal properties to facilitate rapid diffusion across the alveolar membrane into the blood27; the liver is considered to be the predominant metabolising organ because of its high level of enzymatic activity. The fact that toluene and p-xylene are both excreted mainly as metabolites'2 13 and are good substrates for hepatic microsomal cytochrome P-450,28 29 indicates that the total blood flow through the liver, 1-6 Vmin,'7 might be the limiting factor in their in vivo kinetics; perfusion limited kinetics have been suggested for several organic solvents. '8 In addition to almost complete hepatic extraction, the values of Clapp (¢ 1.8 /min) presumably represent an extrahepatic metabolism, a pulmonary excretion of unmetabolised solvent (4-18% of toluene, 4-5% of p-xylene' 22' 22) , and an uptake in adipose tissue2 ' 30 or other tissues. The value of Clapp, 2-3 V/h-kg, found during low level exposure to toluene is the same as that obtained previously for toluene after a comparable dose of solvent [toluene 100 ppm (4- 800 mg/M3 (7.5 mmol/m3), dose dependent kinetics based on the enzymatic induction by phenobarbital have been found in rats. 9 Furthermore, there is evidence that, in man, the metabolic rate of tetrachloroethylene is limited by capacity at exposure levels exceeding 100 ppm (4.2 mmol/m3)33 and that the metabolism of methylene chloride in rats is saturated at exposures in the range 50-1500 ppm (2.1-630-2 mmol/m3).34 Nevertheless, phenobarbital treatment does not cause induction in human subjects exposed to m-xylene, 400 mg/m3 (3-8 mmol/ mi3).9 In the present study it was possible to detect dose dependent changes in Clapp at exposure levels between 0-9-3-2 mmol/m3. In addition to saturated metabolism this may be due, for example, to changes in tissue perfusion.
The decrease in the blood solvent concentration during the latter part of the exposure may, apart from changes in tissue perfusion, be explained by stimulation of metabolising enzymes. Both toluene35 and xylene 28 3637 are known to exert an influence on their metabolising enzymes in rodents. There are also data showing enzyme induction in connection with occupational exposure to styrene and acetone (maximum air concentrations 164 mg/i3 (1-6 mmol/m3) and 571 mg/m3 (9.8 mmol/m3), respectively).38
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